.

Pharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Formulary management
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204150

« Back to Dashboard
NDA 204150 describes DESVENLAFAXINE, which is a drug marketed by Teva Pharms Usa, Alembic Pharms Ltd, Sun Pharma Global, Sandoz Inc, Actavis Labs Fl Inc, Lupin Ltd, West-ward Pharms Int, and Mylan Pharms Inc, and is included in ten NDAs. It is available from one supplier. Additional details are available on the DESVENLAFAXINE profile page.

The generic ingredient in DESVENLAFAXINE is desvenlafaxine succinate. There are fifteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the desvenlafaxine succinate profile page.

Summary for NDA: 204150

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 204150

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DESVENLAFAXINE
desvenlafaxine
TABLET, EXTENDED RELEASE;ORAL 204150 NDA Ranbaxy Pharmaceuticals Inc. 63304-191 63304-191-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-191-30)
DESVENLAFAXINE
desvenlafaxine
TABLET, EXTENDED RELEASE;ORAL 204150 NDA Ranbaxy Pharmaceuticals Inc. 63304-191 63304-191-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-191-90)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength50MG
Approval Date:Mar 4, 2013TE:BCRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength100MG
Approval Date:Mar 4, 2013TE:BCRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc